This rate is higher in the first 48 weeks as the body adjusts to the medication's appetite-suppressing effects, then may stabilize or continue at a slower pace depending on dose escalation and adherence
When and how CBT for BED use GLP-1RAs CBT for BED, as detailed in a manual (Dalle Grave et al., 2024), integrates strategies and procedures from both CBT-E for eating disorders (Dalle Grave & Calugi, 2020
But suppose you dont live near a clinic and cant get to a dermatologist
If youre trying to lose weight or youve already tried GLP-1 medications, a weight loss patch can sound like a dream come true
As of April 2026, retatrutide (LY3437943) remains an investigational drug in Phase 3 clinical trials
Treatment is guided by a licensed provider and tailored to individual recovery needs